<DOC>
	<DOC>NCT00672373</DOC>
	<brief_summary>The purpose of this study is to determine whether Extract of Ginkgo Biloba is effective in the treatment on Tardive dyskinesia</brief_summary>
	<brief_title>Extract of Ginkgo Biloba and Tardive Dyskinesia</brief_title>
	<detailed_description>Tardive dyskinesia(TD) is a common complication of conventional antipsychotic treatment in subjects with schizophrenia. There is no established treatment for TD patients.This disorder remains a significant clinical problem for both patients and physicians for the foreseeable future.</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<criteria>Male or female aged 18 to 60yrs Meeting Diagnostic and Statistical Manual of Mental Diseases, Fourth Edition(DSMIV) criteria for schizophrenia or schizoaffective disorder Abnormal Involuntary Movement Scale (AIMS) score â‰¥2. Patients from whom informed, written consent is obtained. Patients who have been on a fixed dose of antipsychotic medication for at least 4 weeks prior to trial entry. Significant neurological disorder other than TD Substance abuse Significant other medical illness Psychiatric disorder not stabilised Pregnancy or lactation Take antioxidants(such as Vitamin C)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Tardive Dyskinesia</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Extract of Gingko Biloba</keyword>
</DOC>